GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$81.26
+0.44% today
Updated 2026-10-28
Market cap
$10.30B
P/E ratio
19.67
P/S ratio
3.28x
EPS (TTM)
$3.90
Dividend yield
—
52W range
$60 – $101
Volume
1.4M
Globus Medical (GMED) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$81.26
12-Month target
$90.01
2030 Target
—
Intrinsic (DCF)
$139.40
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.6B | $2.5B | $2.9B | $3.5B | $4.2B | $5.1B | $6.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 19.67x (capped 25x) · Margin: 17.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.